Product Information
- Ulixertinib HCl
- BVD-523
- VRT752271
- BVD 523
- BVD523
- VRT 752271
Ulixertinib (BVD-523) orally inhibits ERK1/2, reducing VEGF, myeloma growth, and angiogenesis.
Chemical properties
Technical inquiry about: TM-T7005L Ulixertinib hydrochloride
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.